跳至主要内容
临床试验/JPRN-UMIN000011948
JPRN-UMIN000011948已完成2 期

Efficacy of the combination therapy of Juzen-taiho-to (TJ-48) and ursodeoxycholic acid (UDCA) in HCV-associated chronic liver disease: a prospective, randomized, cross-over study - Efficacy of TJ-48 combined with UDCA in HCV-associated chronic liver disease

Yokohama City University Medical Center0 个研究点目标入组 60 人开始时间: 2013年10月3日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
30years-old 至 80years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Patient who received interferon treatment in previous 24 weeks 2) Patients who received medical Kampo preparations in previous 4 weeks 3) Patients who received the so-called "liver function improving drug" other than UDCA 4) Patients with hepatocellular carcinoma 5)Patients with serious complications 6) Woman in pregnancy or willing to get pregnant 7) Patients who are judged as inadequate for the study

研究者

相似试验